COVID-19 Vaccine

Johnson & Johnson single-shot vaccine 85% effective against severe COVID-19 disease

Johnson & Johnson’s single-shot COVID-19 vaccine, currently in development as part of a partnership between Johnson & Johnson and a team led by Dan Barouch, MD, PhD, of Beth Israel Deaconess Medical Center, was 66% effective at preventing symptomatic disease and 85% effective against preventing severe illness. The results put a third vaccine on the horizon in the U.S. – one that could simplify distribution and expand access to shots in the U.S. and worldwide. (ABC News, January 29, 2021)

COVID-19 Vaccine

Mass. working to educate prisoners about getting the coronavirus vaccine

1,400 prisoners in Massachusetts have gotten the coronavirus vaccine, and officials are holding vaccine education programs to encourage more to do the same. Kathryn Stephenson, MD, MPH of Beth Israel Deaconess Medical Center is among those working on getting more information to prisoners to address their concerns. (WBUR, January 27, 2021)

COVID-19 Vaccine

Baker releases new details on vaccination timeline, locations for Mass. residents

Massachusetts Gov. Charlie Baker detailed on Monday plans to have 103 public vaccination sites open by the end of the week. Suzanne Salamon, MD of Beth Israel Deaconess Medical Center has been taking a lot of calls from patients who are curious about how and when they can get the vaccine and said the public vaccination sites will be a tremendous boost for people who live in independent housing and have been confined in their houses or their apartments. (NBC Boston 10, January 25, 2021)

COVID-19 Vaccine

Johnson & Johnson expects vaccine results soon but lags in production

Johnson & Johnson expects to release critical results from its COVID-19 vaccine trial in two weeks but most likely won’t be able to provide as many doses as expected this spring due to unanticipated manufacturing delays. Dan Barouch, MD, PhD, of Beth Israel Deaconess Medical Center, referenced how simpler logistics behind the vaccination campaigns result in a more successful program. (New York Times, January 13, 2021)